Technical Review of the Gene Technology Regulations 2001 – call for submissions

Overview

The Gene Technology Act 2000, enacted by the Parliament of Australia, was introduced to address the need for a regulatory framework governing the use, handling, and potential risks associated with genetically modified organisms in Australia. This Act provides the legislative basis for the regulation of gene technology activities, ensuring that they are conducted in a manner that protects human health and the environment. The Gene Technology Regulator (the Regulator), established under this Act, is responsible for the administration and enforcement of the regulations. The policy objective of the Act is to ensure the safe development and use of gene technology while also facilitating innovation and maintaining public confidence in the sector. In 2017, the Regulator initiated a technical review of the Gene Technology Regulations 2001 (the Regulations), seeking public submissions to propose amendments aimed at modernising and improving the regulatory framework. This review process involves the release of a Consultation Regulation Impact Statement and a Consultation Quick Guide, which outline the proposed changes and invite feedback from stakeholders. Submissions are to be sent to the Office of the Gene Technology Regulator by 21 February 2018, and while most submissions will be published online, confidential information will be treated as such. The Regulator's goal through this consultation is to refine the regulations to better address contemporary challenges and ensure they effectively support the objectives of the Act.

Scope and Application

The Gene Technology Regulations 2001, subject to the current review and proposed amendments, apply to a broad spectrum of activities and entities within Australia that involve the handling, use, and release of genetically modified organisms (GMOs). This includes individuals, companies, research institutions, and agricultural entities that are involved in any form of gene technology activity, which encompasses the development, manufacture, importation, exportation, and use of GMOs. The geographic scope of these regulations is national, extending across all states and territories in Australia, ensuring a unified approach to the regulation of gene technology activities. There are specific exclusions and exemptions detailed within the regulations themselves, and these may be further refined or expanded through subordinate instruments. The consultation process is aimed at ensuring that the regulations remain effective and relevant to the current scientific and industrial landscape, and submissions are invited from all stakeholders, with the Regulator providing clear guidelines on the submission process and confidentiality protocols. Submissions are to be made by 21 February 2018, with the Regulator accepting written feedback on the proposed amendments and providing a platform for public review once the consultation period concludes.

Key Provisions

The main provisions of the Gazetted legislation C2017G01326 pertain to the Technical Review of the Gene Technology Regulations 2001. Section 1 of the Gazette invites comments from the public on proposed amendments to the Regulations. The proposed amendments are detailed in a Consultation Regulation Impact Statement and a Consultation Quick Guide, both of which are available on the Office of the Gene Technology Regulator (OGTR) website (section 2). Submissions on these amendment proposals and the consultation questions outlined in the documents must be sent to OGTR@health.gov.au or to a physical address provided by the Regulator (section 3). The Act imposes specific obligations on the entities it governs. Firstly, it mandates the Regulator to invite and consider written submissions from the public regarding the proposed amendments (section 4). Secondly, it requires that these submissions be made by a specified date, in this case, 21 February 2018 (section 5). Additionally, it stipulates that any confidential information provided in submissions must be clearly marked and separated from non-confidential material (section 6). Furthermore, it requires that personal details such as signatures, phone numbers, mobile numbers, and fax numbers be excluded from submissions to protect privacy (section 7). Failure to comply with the requirements of this Act may result in various consequences. While the Gazette does not explicitly outline specific offences, penalties, or consequences for non-compliance, it does state that submissions will be published on the OGTR website after the consultation period. This publication requirement means that any non-compliant submissions could be publicly disclosed, potentially leading to reputational or other consequences for the submitter. Additionally, the Act’s emphasis on the confidential treatment of sensitive information implies that any mishandling of such information could lead to legal or administrative repercussions. The exact nature of these consequences, however, is not detailed in the provided text.